Site updated at Wednesday, 22 June 2016

Living with Dementia


Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   

Living with dementia

ataxia4 - symptomatic benefit1 - vascular endothelial growth factor1 - alzheimer's signs1 - apolipoprotein e2 - beta amyloid protein1 - mind diet1 - amnestic mild cognitive impairment1 - motor symptoms1 - amyotrophic lateral sclerosis6 - mild alzheimer's disease1 - zilboorg1 - neurodegenerative diseases1 - dementia and down’s syndrome1 - early alzheimer's disease1 - neurodegenerative disease9 - burden of dementia1 - diet high in carbohydrates1 - american academy of neurology3 - autosomal dominant gene mutation1 - stupidity or foolishness1 - emotional lability1 - dementia sufferers1 - memory decline2 - hiv infection1 - long-term dementia1 - reconceptualization1 - alzheimer's imaging agents1 - high-cholesterol diet1 - beta-amyloid8 -